Literature DB >> 9501279

Betaine dose and treatment intervals in therapy for homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency.

N Sakura1, H Ono, S Nomura, H Ueda, N Fujita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501279     DOI: 10.1023/a:1005331902497

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism.

Authors:  R H Allen; S P Stabler; J Lindenbaum
Journal:  Metabolism       Date:  1993-11       Impact factor: 8.694

2.  Human hepatic methionine biosynthesis. Purification and characterization of betaine:homocysteine S-methyltransferase.

Authors:  W E Skiba; M P Taylor; M S Wells; J H Mangum; W M Awad
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

3.  Effect of betaine on S-adenosylmethionine levels in the cerebrospinal fluid in a patient with methylenetetrahydrofolate reductase deficiency and peripheral neuropathy.

Authors:  T Kishi; I Kawamura; Y Harada; T Eguchi; N Sakura; K Ueda; K Narisawa; D S Rosenblatt
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

  3 in total
  9 in total

1.  Rapid diagnosis and methionine administration: basis for a favourable outcome in a patient with methylene tetrahydrofolate reductase deficiency.

Authors:  N G Abeling; A H van Gennip; H Blom; R A Wevers; P Vreken; H L van Tinteren; H D Bakker
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Betaine in the Brain: Characterization of Betaine Uptake, its Influence on Other Osmolytes and its Potential Role in Neuroprotection from Osmotic Stress.

Authors:  Leena S Knight; Quinn Piibe; Ian Lambie; Christopher Perkins; Paul H Yancey
Journal:  Neurochem Res       Date:  2017-09-16       Impact factor: 3.996

3.  Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.

Authors:  Sarika U Peters; Lynne M Bird; Virginia Kimonis; Daniel G Glaze; Lina M Shinawi; Terry Jo Bichell; Rene Barbieri-Welge; Mark Nespeca; Irina Anselm; Susan Waisbren; Erica Sanborn; Qin Sun; William E O'Brien; Arthur L Beaudet; Carlos A Bacino
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

4.  Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria.

Authors:  Bernd C Schwahn; Dieter Hafner; Thomas Hohlfeld; Nina Balkenhol; Maurice D Laryea; Udo Wendel
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

5.  An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria.

Authors:  Angela Matthews; Trevor N Johnson; Amin Rostami-Hodjegan; Anupam Chakrapani; J Edward Wraith; Stuart J Moat; James R Bonham; Geoffrey T Tucker
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

6.  A study of the treatment of Rett syndrome with folate and betaine.

Authors:  Daniel G Glaze; Alan K Percy; Kathleen J Motil; Jane B Lane; Janet S Isaacs; Rebecca J Schultz; Judy O Barrish; Jeffrey L Neul; William E O'Brien; E O'Brian Smith
Journal:  J Child Neurol       Date:  2009-02-18       Impact factor: 1.987

7.  Titration of betaine therapy to optimize therapy in an infant with 5,10-methylenetetrahydrofolate reductase deficiency.

Authors:  Sema Kalkan Ucar; Ozge Altun Koroğlu; Omer Berk; Mehmet Yalaz; Nilgün Kültürsay; Henk J Blom; Mahmut Coker
Journal:  Eur J Pediatr       Date:  2009-05-12       Impact factor: 3.183

Review 8.  Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.

Authors:  Alina Andras; Gerard Stansby; Monica Hansrani
Journal:  Cochrane Database Syst Rev       Date:  2013-07-19

9.  Cystathionine beta synthase deficiency and brain edema associated with methionine excess under betaine supplementation: Four new cases and a review of the evidence.

Authors:  Bernd C Schwahn; Thomas Scheffner; Hedwig Stepman; Peter Verloo; Anibh M Das; Janice Fletcher; Henk J Blom; Jean-Francois Benoist; Bruce A Barshop; Jaime J Barea; Annette Feigenbaum
Journal:  JIMD Rep       Date:  2020-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.